MC Echave, LS Burgo, JL Pedraz… - Current pharmaceutical …, 2017 - ingentaconnect.com
Tissue engineering is considered one of the most important therapeutic strategies of regenerative medicine. The main objective of these new technologies is the development of …
VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
S Ranganathan, K Balagangadharan… - International journal of …, 2019 - Elsevier
Fractures and injuries pertaining to bone tissue usually take prolonged periods for its natural healing. To overcome this problem, the field of bone tissue engineering (BTE) has acquired …
Bone-related diseases are major contributors to morbidity and mortality in elderly people and the current treatments result in insufficient healing and several complications. One of the …
JG Lyons, MA Plantz, WK Hsu, EL Hsu… - … in Bioengineering and …, 2020 - frontiersin.org
This review article addresses the various aspects of nano-biomaterials used in or being pursued for the purpose of promoting bone regeneration. In the last decade, significant …
The suffering from organ dysfunction due to damaged or diseased tissue/bone has been globally on the rise. Current treatment strategies for non-union bone defects include: the use …
Y Chen, N Kawazoe, G Chen - Acta biomaterialia, 2018 - Elsevier
Although bone is regenerative, its regeneration capacity is limited. For bone defects beyond a critical size, further intervention is required. As an attractive strategy, bone tissue …
HM Khan, X Liao, BA Sheikh, Y Wang, Z Su… - Journal of Materials …, 2022 - pubs.rsc.org
Smart biomaterials have been rapidly advancing ever since the concept of tissue engineering was proposed. Interacting with human cells, smart biomaterials can play a key …
L Kou, S Xiao, R Sun, S Bao, Q Yao, R Chen - Drug delivery, 2019 - Taylor & Francis
Osteoarthritis (OA) is a progressive and degenerative disease, which is no longer confined to the elderly. So far, current treatments are limited to symptom relief, and no valid OA …